// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The development of generic versions of innovator medicines is a global public health need.
We live in an age where the use of computers and software systems are directly integrated into th
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and